Generic Clearance for Methodological Studies in the Population Assessment of Tobacco and Health (PATH) Study (NIDA)

ICR 201606-0925-002

OMB: 0925-0675

Federal Form Document

Forms and Documents
Document
Name
Status
Supplementary Document
2016-08-15
Supporting Statement A
2016-08-15
Supplementary Document
2016-06-06
Supplementary Document
2016-06-06
Supplementary Document
2016-06-06
Supplementary Document
2016-06-06
Supplementary Document
2016-06-06
Supplementary Document
2016-06-06
Supporting Statement B
2016-08-15
IC Document Collections
IC ID
Document
Title
Status
ICR Details
0925-0675 201606-0925-002
Active 201303-0925-001
HHS/NIH 18997
Generic Clearance for Methodological Studies in the Population Assessment of Tobacco and Health (PATH) Study (NIDA)
Reinstatement without change of a previously approved collection   No
Regular
Approved with change 08/15/2016
Retrieve Notice of Action (NOA) 06/07/2016
NIH will submit individual collections under this generic clearance to OMB. OMB will strive to provide feedback on the individual collections within ten working days, whenever possible. Standard incentive amount is remuneration is $40.00; requests for higher levels must be justified (e.g., very difficult recruitments), two-hour focus groups, etc.
  Inventory as of this Action Requested Previously Approved
08/31/2019 36 Months From Approved
60,000 0 0
89,250 0 0
0 0 0

This is a reinstatement without change (of OMB number 0925-06764, expiration date 5/31/2016) for the Population Assessment of Tobacco and Health (PATH) Study to conduct methodological substudies to improve its methods for data and biospecimen collection. The PATH Study is collecting behavioral data and biospecimens among a national longitudinal cohort to assess within-person changes and between-person differences in tobacco-product use behaviors and related health conditions over time. Its longitudinal, population-based data will help to enhance the evidence base that informs FDA’s regulatory actions under the Family Smoking Prevention and Tobacco Control Act (TCA) to protect the Nation’s public health and reduce its burden of tobacco-related morbidity and mortality.

US Code: 42 USC 285o Name of Law: NIDA in partnership with FDA
  
None

Not associated with rulemaking

  81 FR 12913 03/11/2016
81 FR 35369 06/02/2016
No

0

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 60,000 0 0 40,000 0 20,000
Annual Time Burden (Hours) 89,250 0 0 0 0 89,250
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$2,916,358
Yes Part B of Supporting Statement
No
No
No
No
Uncollected
Tawanda Abdelmouti 240 276-5530 ta401@nih.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
06/07/2016


© 2024 OMB.report | Privacy Policy